Compliance, Conflict of Interest, Innovation and Marketing

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Compliance

Conflict of Interest

Innovation

Marketing

How Pharma Can Fix Its Reputation and Its Business at the Same Time

Harvard Business Review

FEBRUARY 3, 2017

By that I mean that pharma companies should develop innovative treatments for pervasive unmet medical needs; avoid corruption, collusion, and other unethical marketing practices; and make sure that their products reach as many patients around the world as possible. Mitigate the risk of unethical conduct. Enhance corporate reputations.

Reputation

Reputation Pharmaceuticals Price Business Model

What You Should Know About Dodd-Frank and What Happens If It’s Rolled Back

Harvard Business Review

MARCH 2, 2017

And in the market more broadly, there is a sense that certain kinds of bad assets should be avoided.” “First, the costs of compliance with these stress tests and disclosures and new capital rules on banks and other financial firms are extremely high. We’ve [got] growth prospects in the stock market.

Banking

Banking Crisis System Compliance

Leadership Digital

How Pharma Can Fix Its Reputation and Its Business at the Same Time

What You Should Know About Dodd-Frank and What Happens If It’s Rolled Back

Stay Connected